Martin S. Engler
Papers
1
Total Citations
15
H-Index
1
About
Martin S. Engler is a leading researcher in interventional cardiology, with a focused expertise in the optimization of drug-coated balloon (DCB) technology for percutaneous transluminal angioplasty. His work critically addresses the challenge of unintended particle loss during the handling and deployment of paclitaxel-coated devices, which can compromise drug delivery to target tissues and lead to systemic side effects. In his landmark 2020 study, Engler pioneered a novel robotic arm system to systematically and reproducibly evaluate drug abrasion under controlled contact conditions. This methodological innovation provided the first quantitative, standardized assessment of particle loss across eight different DCB types, establishing a new benchmark for device safety and efficacy. With 15 citations, this work has become a foundational reference for engineers and clinicians seeking to improve drug transfer efficiency. Engler’s contributions are vital for advancing the precision of angioplasty, directly impacting patient outcomes by minimizing off-target drug embolization and enhancing the therapeutic performance of next-generation interventional tools.
Research Focus
Key Achievements
Top Papers
- 1